Related Experiment Video
Updated: Jun 25, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Cardiovascular function and dysfunction in sickle cell anemia
1Department of Medicine (Cardiology), Los Angeles County+University of Southern California Medical Center, CA 90033, USA. jhaywood@hsc.usc.edu
Insights
Sickle cell anemia (SCA) impacts the heart, causing enlarged heart and myocardial ischemia due to anemia and blood viscosity. Key mortality risks include hypertension and pulmonary hypertension.
Area of Science:
- Hematology
- Cardiology
- Pathophysiology
Background:
- Sickle cell anemia (SCA) was identified in 1910 and remains a significant clinical entity.
- SCA presents complex pathophysiologic mechanisms, particularly concerning cardiopulmonary and circulatory systems.
- Understanding SCA's cardiovascular impact is crucial for patient outcomes.
Purpose of the Study:
- To review the pathophysiologic mechanisms of cardiopulmonary and circulatory disorders in sickle cell anemia.
- To highlight the relationship between SCA and cardiac complications such as cardiomegaly and myocardial ischemia.
- To identify mortality risk factors associated with sickle cell anemia.
Main Methods:
- Review of existing data and literature on sickle cell anemia and its cardiovascular manifestations.
- Analysis of pathophysiologic pathways linking anemia, blood viscosity, and cardiac dysfunction.
- Identification of clinical factors contributing to mortality in SCA patients.
Main Results:
- Cardiomegaly in SCA is linked to increased cardiac workload from anemia.
- Myocardial ischemia results from severe anemia, microthrombi, and increased blood viscosity.
- Sudden death can occur due to myocardial infarction or rhythm disturbances; hypertension and pulmonary hypertension are key mortality risks.
Conclusions:
- Sickle cell anemia significantly affects cardiovascular health, leading to conditions like cardiomegaly and myocardial ischemia.
- Early identification and management of risk factors such as hypertension are vital for improving survival in SCA patients.
- Continued research into SCA's complex mechanisms is essential for developing effective therapeutic strategies.
Abstract:
The 100th anniversary of the discovery of sickle cell anemia (SCA) as a distinct clinical entity by James B. Herrick in 1910 will soon be a reality. SCA continues to present opportunities for elemental observations of basic science and pathophysiologic clinical mechanisms-in particular, those associated with cardiopulmonary and circulatory disorders. Data indicate that cardiomegaly results from increased work caused by the anemia and that myocardial ischemia may result from the combined effects of severe anemia, microthrombi, and increased blood viscosity producing myocardial dysfunction, scarring, and elevated filling pressures. Sudden death has resulted from frank myocardial infarction and ischemia-induced rhythm disturbances. Myocardial injury may also be associated with bone marrow embolism. Mortality risk factors include systemic hypertension, pulmonary hypertension, and possibly subclinical electrical instability.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pathophysiology of Heart Failure
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pathophysiology of Cardiac Performance
